Total Payments
$2,113
2024 Payments
$473.46
Companies
21
Transactions
143
Medicare Patients
8,117
Medicare Billing
$282,683
Payment Breakdown by Category
Food & Beverage$2,113 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,113 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $802.00 | 57 | $0 (2024) |
| Novo Nordisk Inc | $352.25 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $235.28 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $184.96 | 9 | $0 (2023) |
| Esperion Therapeutics, Inc. | $113.32 | 7 | $0 (2021) |
| GlaxoSmithKline, LLC. | $88.60 | 6 | $0 (2024) |
| Amgen Inc. | $50.70 | 3 | $0 (2023) |
| Lilly USA, LLC | $40.01 | 3 | $0 (2024) |
| Exact Sciences Corporation | $39.63 | 3 | $0 (2023) |
| EISAI INC. | $29.10 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $473.46 | 32 | ABBVIE INC. ($348.17) |
| 2023 | $558.68 | 36 | AbbVie Inc. ($321.92) |
| 2022 | $400.44 | 26 | ABBVIE INC. ($131.91) |
| 2021 | $581.84 | 43 | Novo Nordisk Inc ($177.53) |
| 2020 | $98.40 | 6 | Astellas Pharma US Inc ($23.68) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: VACCINE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Biological | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: VACCINES | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: RESPIRATORY | ||||||
| 04/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 04/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,372 | 3,040 | $192,091 | $80,795 |
| 2022 | 40 | 3,049 | 3,922 | $248,877 | $109,477 |
| 2021 | 33 | 2,203 | 2,660 | $178,519 | $75,830 |
| 2020 | 15 | 493 | 530 | $39,500 | $16,581 |
Total Patients
8,117
Total Services
10,152
Medicare Billing
$282,683
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 143 | 143 | $23,595 | $17,455 | 74.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 217 | $43,565 | $15,449 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 88 | $12,180 | $4,767 | 39.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 183 | 244 | $12,932 | $4,002 | 31.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 52 | 53 | $5,406 | $3,996 | 73.9% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 16 | 16 | $4,560 | $3,860 | 84.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 189 | 270 | $12,150 | $3,531 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 206 | 400 | $4,000 | $3,331 | 83.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 91 | 105 | $9,975 | $3,017 | 30.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 72 | 72 | $10,800 | $2,527 | 23.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 177 | 261 | $9,135 | $2,461 | 26.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 186 | 233 | $7,689 | $2,412 | 31.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 188 | 226 | $6,780 | $1,720 | 25.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 68 | 68 | $3,400 | $1,663 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 54 | $1,944 | $1,536 | 79.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 11 | 11 | $1,650 | $1,413 | 85.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $2,310 | $1,129 | 48.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 101 | 115 | $3,450 | $936.96 | 27.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $1,836 | $864.27 | 47.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $750.00 | $711.00 | 94.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 23 | 23 | $1,035 | $556.60 | 53.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 27 | 31 | $1,457 | $458.18 | 31.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 23 | 23 | $1,150 | $435.16 | 37.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 11 | 11 | $495.00 | $417.23 | 84.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 26 | 43 | $3,010 | $380.12 | 12.6% |
About Elizabeth Bunch
Elizabeth Bunch is a Family Medicine healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2017. The National Provider Identifier (NPI) number assigned to this provider is 1699201327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Bunch has received a total of $2,113 in payments from pharmaceutical and medical device companies, with $473.46 received in 2024. These payments were reported across 143 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,113).
As a Medicare-enrolled provider, Bunch has provided services to 8,117 Medicare beneficiaries, totaling 10,152 services with total Medicare billing of $282,683. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Murfreesboro, TN
- Active Since 05/01/2017
- Last Updated 06/25/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1699201327
Products in Payments
- VRAYLAR (Drug) $641.70
- REXULTI (Drug) $184.96
- MYRBETRIQ (Drug) $163.01
- Ozempic (Drug) $147.62
- NEXLETOL (Drug) $113.32
- QULIPTA (Drug) $85.27
- UBRELVY (Drug) $75.03
- SHINGRIX (Biological) $49.51
- JARDIANCE (Drug) $39.94
- Cologuard Collection Kit (Device) $39.63
- Myrbetriq (Drug) $39.51
- TRELEGY ELLIPTA (Drug) $39.09
- Otezla (Drug) $34.40
- Wegovy (Drug) $32.65
- Rybelsus (Drug) $31.59
- Dayvigo (Drug) $29.10
- INSPIRE (Device) $23.68
- TRINTELLIX (Drug) $19.48
- Saxenda (Drug) $19.05
- ENTRESTO (Drug) $18.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Murfreesboro
Dr. Scott Eller, M.d, M.D
Family Medicine — Payments: $18,623
Family Medicine $18,623
Dr. Thomas Helton, Md, MD
Family Medicine — Payments: $15,111
Family Medicine $15,111
Dr. Laura Born, Md, MD
Family Medicine — Payments: $13,627
Family Medicine $13,627
Dr. Adam Childs, M.d, M.D
Family Medicine — Payments: $13,253
Family Medicine $13,253
Dennis Carter, Md, MD
Family Medicine — Payments: $11,679
Family Medicine $11,679
Nicholas Cote, D.o, D.O
Family Medicine — Payments: $10,359
Family Medicine $10,359